Browsing: Diagnostics

This section provides information on recently published research.

Fluidigm COVID-19 Campus Safeguard Program Improves Availability of Noninvasive, Saliva-Based SARS-CoV-2 Tests for Higher Education Institutions. SOUTH SAN FRANCISCO, Calif., Oct. 08,  Fluidigm Corporation (Nasdaq:FLDM), announced a program to expand availability of Fluidigm® COVID-19 tests for U.S. colleges and universities. The Fluidigm COVID-19 Campus Safeguard Program will provide millions of…

Read More

The National Institutes of Health (NIH) Biomedical Advanced Research and Development Authority (BARDA), announced a third round of contract awards for scale-up and manufacturing of new COVID-19 testing technologies. The six new Rapid Acceleration of Diagnostics (RADx) initiative contracts total $98.35 million for point-of-care and other novel test approaches that provide…

Read More

An insightful article on COVID-19 testing was authored by Mara G. Aspinall co-founder of the biomedical diagnostics program at Arizona State University’s College of Health Solutions. Published October 9th.  According to Aspinall, “PCR tests cost too much and take too long, too few will be tested and the results will arrive…

Read More

If businesses are not open and kids not in school, we are losing the war against COVID. A war we could and should be winning.  Science and technology can defeat this invader that is destroying the global economy and taking and shattering millions of lives. But we need to unleash…

Read More